Browse > Article
http://dx.doi.org/10.15324/kjcls.2021.53.3.225

Distribution and Antimicrobial Resistance of Non-Tuberculous Mycobacteria during 2015~2020: A Single-Center Study in Incheon, South Korea  

Kim, Jiwoo (Department of Laboratory Medicine, International St. Mary's Hospital, College of Medicine, Catholic Kwandong University)
Ju, Hyo-Jin (Department of Medical Humanities, College of Medicine, Catholic Kwandong University)
Koo, Jehyun (Department of Laboratory Medicine, International St. Mary's Hospital, College of Medicine, Catholic Kwandong University)
Lee, Hyeyoung (Department of Laboratory Medicine, International St. Mary's Hospital, College of Medicine, Catholic Kwandong University)
Park, Hyeonhwan (Catholic Kwandong University Graduate School of Healthcare Convergence)
Song, Kyungcheol (Department of Laboratory Medicine, International St. Mary's Hospital, College of Medicine, Catholic Kwandong University)
Kim, Jayoung (Department of Laboratory Medicine, International St. Mary's Hospital, College of Medicine, Catholic Kwandong University)
Publication Information
Korean Journal of Clinical Laboratory Science / v.53, no.3, 2021 , pp. 225-232 More about this Journal
Abstract
This study sought to investigate the distribution, antimicrobial resistance rate, and bacterial co-infection frequency of non-tuberculous mycobacteria (NTM) in a single center in Incheon, South Korea. A total of 8,258 specimens submitted for tuberculosis (TB)/NTM real-time PCR tests during the years 2015 to 2020 were retrospectively reviewed. In total, 296 specimens (3.6%) were NTM positive, and the positivity increased from 2.5% (30/1,209) in 2015 to 3.8% (66/1,740) in 2020. Of 296 NTM specimens, 54.7% (162/296) were identified as the Mycobacterium avium complex (MAC) followed by the Mycobacterium abscessus complex (MABC) 20.9% (62/296), M. fortuitum 6.4% (19/296) and M. flavescens 3.4% (10/296). Of the NTM-positive specimens, 76.7% (227/296) were tested for drug resistance. The results showed multidrug-resistant NTM in 40.1% (91/227) and extensively drug-resistant NTM in 59.9% (136/227) of these specimens. Of the 145 isolates taken for bacterial culture, bacteria/fungi co-infection with NTM accounted for 43.4% (63/145), in which the most common bacterial species was Klebsiella pneumonia (23.8%, 15/63). This study is the first report on the distribution and antimicrobial resistance of NTM in Incheon. As the proportion of NTM infections increases, active treatment and thorough infection control are required for effective management.
Keywords
Co-infection; Drug-resistant; Incheon; Non-tuberculous mycobacteria;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Park YM, Kim CY, Park MS, Kim YS, Chang J, Kang YA. Age-and sex-related characteristics of the increasing trend of nontuberculous mycobacteria pulmonary disease in a tertiary hospital in South Korea from 2006 to 2016. Korean J Intern Med. 2020;35:1424-1431. https://doi.org/10.3904/kjim.2019.395   DOI
2 Olivier KN, Weber DJ, Wallace RJ Jr, Faiz AR, Lee JH, Zhang Y, et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med. 2003;167: 828-834. https://doi.org/10.1164/rccm.200207-678OC   DOI
3 Falkinham JO. Nontuberculous mycobacteria in the environment. Clin Chest Med. 2002;23:529-551. https://doi.org/10.1016/s0272-5231(02)00014-x   DOI
4 Marras TK, Daley CL. Epidemiology of human pulmonary infection with non-tuberculous mycobacteria. Clin Chest Med. 2002;23:553-567. https://doi.org/10.1016/s0272-5231(02)00019-9   DOI
5 Sharma SK, Upadhyay V. Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases. Indian J Med Res. 2020;152:185-226. https://doi.org/10.4103/ijmr.IJMR_902_20   DOI
6 WHO. Global tuberculosis report 2018. Geneva: WHO; 2018.
7 Hong SK, Hur SH, Seog HK. Distribution and antibiotic susceptibility patterns of genus mycobacterium at a private hospital, Korea. J Exp Biomed Sci. 2013;19:132-141.
8 Hoefsloot W, Ingen JV, Andrejak C, Ngeby KA, Bauriaud R, Bemer P, et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples. Eur Respir J. 2013;42: 1604-1613. https://doi.org/10.1183/09031936.00149212   DOI
9 Primm TP, Lucero CA, Falkinham JO 3rd, Health impacts of environmental mycobacteria. Clin Microbiol Rev. 2004;17:98-106. https://doi.org/10.1128/CMR.17.1.98_106.2004   DOI
10 Baek HG. Study on the prevalence of lung disease of non-tuberculosis mycobacterium isolated from respiratory specimens in Gwangju Second Hospital over the last 10 years. Korean J Clin Lab Sci. 2020;52:349-355. https://doi.org/10.154324/kjcls.20.52.4.349   DOI
11 Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard-3rd ed, M24-M62. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
12 Joint Committee for the Revision of Korean Guidelines for Tuberculosis, Korean Centers for Disease Control and Prevention. Korean Guidelines for Tuberculosis. 4th ed. 2020.
13 Park SC, Kang MJ, Han CH, Lee SM, Kim CJ, Lee JM, et al. Prevalence, incidence, and mortality of nontuberculous mycobacterial infection in Korea: a nationwide population-based study. BMC Pulmonary Medicine. 2019;19:140-148. https://doi.org/10.1186/s12890-019-0901-z   DOI
14 Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard-3rd ed, M24. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
15 Gorsich EE, Etienne RS, Medlock J, Beechler BR, Spaan M, Spaan RS, et al. Opposite outcomes of coinfection at individual and population scales. PNAS. 2018;115:7545-7550. https://doi.org/10.1073/pnas.1801095115   DOI
16 Geurts K, Zweijpfenning SMH, Pennings LJ, Schildkraut JA, Boeree MJ, MagisEscurra C, et al. Nontuberculous mycobacterial pulmonary disease and Aspergillus co-infection: bonnie and clyde?. Eur Respir J. 2019;54:1900117. https://doi.org/10.1183/13993003.00117-2019   DOI
17 Henkle E, Hedberg K, Schafer S, Novosad S, Winthrop KL. Population-based incidence of pulmonary nontuberculous mycobacterial disease in Oregon 2007 to 2012. Ann Am Thorac Soc. 2015;12:642-647. https://doi.org/10.1513/AnnalsATS.201412-559OC   DOI
18 Van lugen J, Hoefsloot W, Dekhuijzen PNR, Boeree MJ, Van soolingen D. The changing pattern of clinical Mycobacterium avium isolation in the Netherlands. Int J Tuberc Lung Dis. 2010;14: 1176-1180. PMID: 20819265
19 Lim YK, Kweon OH, Kim HR, Kim TH, Lee MK. Impact of bacterial and viral coinfection in community-acquired pneumonia in adults. Diagn Microbiol Infect Dis. 2019;94:50-54. https://doi.org/10.1016/j.diagmicrobio.2018.11.014   DOI
20 Hong KS, Ahn KH, Choi EY, Jin HJ, Shin KC, Chung JH, et al. Microbiologic distribution and clinical features of nontuberculous mycobacteria in the tertiary hospital in Daegu. Yeungnam Univ J Med. 2015;32:71-79. https://doi.org/10.12701/yujm.2015.32.2.71   DOI
21 Jeon KM, Kwon OJ, Lee NY, Kim BJ, Kook YH, Lee SH, et al. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. Am J Respir Crit Care Med. 2009;180:896-902. https://doi.org/10.1164/rccm.200905-0704OC   DOI
22 Lee SH, Yoo HK, Kim SH, Koh WJ, Kim CK, Park YK, et al. The drug resistance profile of Mycobacterium abscessus group strains from Korea. Ann Lab Med. 2014;34:31-37. https://doi.org/10.3343/alm.2014.34.1.31   DOI
23 Huh KM, Jung JH, Hong JW, Kim MY, Ahn JG, Kim JH, et al. Impact of nonpharmaceutical interventions on the incidence of respiratory infections during the coronavirus disease 2019 (COVID-19) outbreak in Korea: a nationwide surveillance study. Clin Infect Dis. 2021;72:184-191. https://doi.org/10.1093/cid/ciaa1682
24 Daley CL, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med. 2002;23:553-567. https://doi.org/10.1016/S0272-5231(02)00019-9   DOI
25 Sakatani M. The non-tuberculous mycobacteriosis. Kekkaku. 2005;80:25-30.
26 Kim NH, Yi JY, Chang CL. Recovery rates of non-tuberculous mycobacteria from clinical specimens are increasing in Korean tertiary-care hospitals. J Korean Med Sci. 2017;32:1263-1267. https://doi.org/10.3346/jkms.2017.32.8.1263   DOI
27 Jankovic M, Samarziha M, Sabol I, Jakopivic M, Jankovic K, Zmak L, et al. Geographical distribution and clinical relevanceof non-tuberculous mycobacteria in Croatia. Int J Tuberc Lung Dis. 2013;17:836-841. https://doi.org/10.5588/ijtld.12.0843   DOI
28 Panagiotou M, Papaioannou AI, Kostikas K, Paraskeua M, Velentza E, Kanellopoulou M, et al. The epidemiology of pulmonary nontuberculous mycobacteria: data from a general hospital in Athens, Greece, 2007-2013. Pulm Med. 2014;2014:894976. https://doi.org/10.1155/2014/894976   DOI